Stephen C. Glover
2023
In 2023, Stephen C. Glover earned a total compensation of $993.2K as Co-Founder, Chief Executive Officer President and Chairman at ZyVersa Therapeutics, a 33% decrease compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $218,217 |
| Salary | $550,000 |
| Total | $993,217 |
Glover received $550K in salary, accounting for 55% of the total pay in 2023.
Glover also received $225K in bonus and $218.2K in option awards.
Rankings
In 2023, Stephen C. Glover's compensation ranked 1,226th out of 2,978 executives tracked by ExecPay. In other words, Glover earned more than 58.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,226 out of 2,978 | 59th |
Division Manufacturing | 727 out of 1,637 | 56th |
Major group Chemicals And Allied Products | 486 out of 906 | 46th |
Industry group Drugs | 474 out of 869 | 46th |
Industry Pharmaceutical Preparations | 328 out of 627 | 48th |
Source: SEC filing on September 9, 2024.
Glover's colleagues
We found two more compensation records of executives who worked with Stephen C. Glover at ZyVersa Therapeutics in 2023.